» Articles » PMID: 21791938

Risk Factors for Pulmonary Artery Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia

Overview
Journal Neonatology
Publisher Karger
Date 2011 Jul 28
PMID 21791938
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the potential importance of pulmonary artery hypertension (PAH) in preterm infants with bronchopulmonary dysplasia (BPD), little is known about the risk factors for PAH.

Objectives: To investigate the risk factors for PAH in preterm infants with BPD.

Methods: Infants diagnosed with BPD were assigned to the PAH group or non-PAH group except for infants with mild BPD who had no PAH. PAH was diagnosed on the basis of echocardiograms demonstrating elevated right ventricle pressure beyond the postnatal age of 2 months. Logistic regression analysis was done for the multivariate assessment of the risk factors for PAH in preterm infants with moderate or severe BPD.

Results: A total of 98 infants among 145 infants with BPD were divided into a PAH group (n = 25) or non-PAH group (n = 73), while the remaining 47 infants had mild BPD with no PAH. Among the study patients, survival rate of the PAH group was significantly lower than that of the non-PAH group. Infants with PAH had more severe cases of BPD and underwent longer durations of oxygen therapy, conventional or high-frequency ventilation, and hospitalization compared to those without PAH. Low 5-min Apgar scores (≤6; relative risk (RR) 6.2; 95% confidence interval (CI) 1.4-28.0; p = 0.017) and oligohydramnios (RR 7.7; 95% CI 2.0-29.6; p = 0.030) were found to be significant risk factors for PAH according to multivariate analysis.

Conclusions: The present study shows that oligohydramnios is a specific risk factor for PAH in preterm infants with moderate or severe BPD.

Citing Articles

Cardiovascular Sequelae of Bronchopulmonary Dysplasia in Preterm Neonates Born before 32 Weeks of Gestational Age: Impact of Associated Pulmonary and Systemic Hypertension.

Pharande P, Sehgal A, Menahem S J Cardiovasc Dev Dis. 2024; 11(8).

PMID: 39195141 PMC: 11354795. DOI: 10.3390/jcdd11080233.


Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants.

Hong K, Shin S, Kim E, Kim H BMC Pediatr. 2024; 24(1):467.

PMID: 39033281 PMC: 11264936. DOI: 10.1186/s12887-024-04943-4.


Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors.

Bae S, Kim S, Yun J, Lee H, Hahn W, Park S Pediatr Res. 2024; 96(5):1251-1257.

PMID: 38734814 DOI: 10.1038/s41390-024-03232-1.


First-year outcomes of very low birth weight preterm singleton infants with hypoxemic respiratory failure treated with milrinone and inhaled nitric oxide (iNO) compared to iNO alone: A nationwide retrospective study.

Chang Y, Liu J, Chen W, Tseng C, See L PLoS One. 2024; 19(5):e0297137.

PMID: 38722851 PMC: 11081351. DOI: 10.1371/journal.pone.0297137.


Serial tissue Doppler imaging in the evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension among extremely preterm infants: a prospective observational study.

Gopagondanahalli K, Abdul Haium A, Vora S, Sundararaghavan S, Ng W, Choo T Front Pediatr. 2024; 12:1349175.

PMID: 38646509 PMC: 11026596. DOI: 10.3389/fped.2024.1349175.